NNovo Nordisk Read More Novo Nordisk’s Pipeline Delivers Two Wins as Stock Sinks to Oversold Territory2026-04-27 Novo Nordisk secures rare disease and pediatric diabetes milestones, but shares fall 21% YTD on GLP-1 competition and…